Clinical Science

Clinical Validation of Cold-Pressed Black Seed Oil

By Dr. Marcus Vance, Director of Clinical Research • June 8, 2026

Black Seed Oil, derived from the seeds of Nigella sativa, has been revered for thousands of years as a multi-functional therapeutic agent. Modern clinical pharmacology is now validating many of these traditional claims, focusing heavily on its primary bioactive compound, Thymoquinone (TQ).

The Role of Thymoquinone

Thymoquinone is a powerful lipophilic antioxidant that exhibits protective effects across multiple systemic networks. Our cold-pressed black seed oil is standardized to guarantee high concentrations of TQ, ensuring consistent physiological efficacy.

Primary Physiological Benefits

  • Immune Modulation: TQ supports the regulation of inflammatory cytokines (such as IL-6 and TNF-alpha), helping the body maintain balanced immune responses.
  • Cardiovascular Support: Research indicates that daily supplementation helps support healthy lipid profiles and arterial elasticity.
  • Bronchial Health: TQ aids in relaxing smooth muscle tissues in the respiratory system, promoting clear airways.

Clinical Trial Insights

Recent double-blind, placebo-controlled trials have demonstrated that a daily dose of 1,000mg to 2,000mg of cold-pressed Nigella sativa oil leads to significant improvements in metabolic and inflammatory biomarkers over an 8-week period.

Biomarker CheckedOutcome in Treatment GroupSignificance (p-value)
Fasting Blood Sugar-12.5% Average Reductionp < 0.05
LDL Cholesterol-9.8% Average Reductionp < 0.01
High-Sensitivity CRP-15.4% Average Reductionp < 0.05

Quality & Sourcing Parameters

To maintain chemical integrity, we cold-press our seeds strictly below 45°C (113°F) without using chemical solvents like hexane. The oil is then stored in amber glass bottles under a nitrogen blanket to prevent oxidation and ensure maximum shelf-life stability.